DFT study on interaction of anticancer drugs with Pd2L4 metallo-organic cage carrier
Mahnoor Ehsan1, Muhammad Aetizaz1, Maria Maqbool1
1Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, KPK, 22060, Pakistan.
Abstract:
Cancer is a life-threatening disease that originates from uncontrolled abnormal cell growth, spreading through metastasis. Conventional chemotherapy employs drugs that lack selectivity, thus causing severe toxicity to healthy tissues. To overcome these limitations, advanced drug delivery systems are crucial for enhancing therapeutic efficacy while minimizing side effects. In this study, a supramolecular metallo-organic Pd2L4 cage is explored as a potential carrier to effectively bind with chemotherapeutic drugs, nitrosourea and fluorouracil. The results revealed that nitrosourea is adsorbed onto the metallo-organic cage, whereas fluorouracil is encapsulated within the central cavity. Interaction energy analysis indicates a stronger interaction of fluorouracil with Pd2L4 (i.e., -36.34 kcal/mol) compared to nitrosourea (i.e., -28.43 kcal/mol). Thermodynamic assessments confirm favorable drug-cage interactions. Electronic structure analysis demonstrates a significant increase in the energy gap upon complexation, from 3.88 eV in the bare cage to 6.67 eV and 6.81 eV for nitrosourea@Pd2L4 and fluorouracil@Pd2L4, respectively. In contrast, UV-Vis spectroscopy shows a substantial red shift of the dominant absorption bands from 326 nm for the bare cage to 363 nm and 418 nm upon drug binding, arising from newly formed host-guest charge-transfer-assisted excited states. Frontier molecular orbital (FMO) analysis suggests palladium-induced d-d transition. Non-covalent interaction (NCI) and quantum theory of atoms in molecules (QTAIM) analyses confirm stabilization via van der Waals forces, with stronger interactions observed in fluorouracil@Pd2L4. These findings provide computational evidence for the encapsulation capability of the Pd2L4 cage toward anticancer drugs, particularly fluorouracil, and offer a theoretical foundation for the rational design of metallo-organic cage-based interaction platforms, subject to future experimental validation.
Insights
This study explores a metallo-organic cage (Pd2L4) for delivering anticancer drugs. The cage effectively binds fluorouracil and nitrosourea, showing promise for targeted cancer therapy.
Area of Science:
- Supramolecular Chemistry
- Computational Chemistry
- Materials Science
Background:
- Conventional chemotherapy faces limitations due to drug toxicity and lack of selectivity.
- Advanced drug delivery systems are essential for improving cancer treatment efficacy and reducing side effects.
- Metallo-organic cages offer potential as novel platforms for targeted drug delivery.
Purpose of the Study:
- To investigate the encapsulation and binding capabilities of a supramolecular metallo-organic Pd2L4 cage with anticancer drugs.
- To computationally assess the interactions between the Pd2L4 cage and nitrosourea and fluorouracil.
- To provide theoretical insights for designing metallo-organic cage-based drug delivery systems.
Main Methods:
- Computational modeling including interaction energy analysis, thermodynamic assessment, and electronic structure analysis.
- UV-Vis spectroscopy to study optical properties upon drug binding.
- Frontier molecular orbital (FMO), Non-covalent Interaction (NCI), and Quantum Theory of Atoms in Molecules (QTAIM) analyses.
Main Results:
- The Pd2L4 cage effectively binds both nitrosourea (adsorption) and fluorouracil (encapsulation).
- Fluorouracil exhibits stronger interaction with the Pd2L4 cage (-36.34 kcal/mol) compared to nitrosourea (-28.43 kcal/mol).
- Complexation significantly increases the cage's energy gap and causes a red shift in UV-Vis absorption bands, indicating charge-transfer interactions.
Conclusions:
- The Pd2L4 cage demonstrates significant potential for encapsulating anticancer drugs, particularly fluorouracil.
- Computational analyses confirm favorable drug-cage interactions and provide a theoretical basis for rational design.
- This study lays the groundwork for developing novel metallo-organic cage-based drug delivery platforms for cancer therapy.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules

